| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L Prensa, M Cossette, A Paren. Dopaminergic innervation of human basal ganglia. Journal of chemical neuroanatomy. vol 20. issue 3-4. 2001-05-24. PMID:11207419. |
dopaminergic innervation of human basal ganglia. |
2001-05-24 |
2023-08-12 |
human |
| L Prensa, M Cossette, A Paren. Dopaminergic innervation of human basal ganglia. Journal of chemical neuroanatomy. vol 20. issue 3-4. 2001-05-24. PMID:11207419. |
this paper summarises the results of some of our recent tyrosine hydroxylase (th) immunohistochemical studies of the dopaminergic innervation of the human basal ganglia. |
2001-05-24 |
2023-08-12 |
human |
| L Prensa, M Cossette, A Paren. Dopaminergic innervation of human basal ganglia. Journal of chemical neuroanatomy. vol 20. issue 3-4. 2001-05-24. PMID:11207419. |
we postulate that this extrastriatal innervation, which allows nigral dopaminergic neurons to directly affect the pallidum and subthalamic nucleus, plays a critical role in the functional organisation of human basal ganglia. |
2001-05-24 |
2023-08-12 |
human |
| D Alvarez Fischer, M K Schäfer, B Ferger, S Gross, R Westermann, E Weihe, K Kuschinsk. Sensitization to the behavioural effects of cocaine: alterations in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved. Naunyn-Schmiedeberg's archives of pharmacology. vol 363. issue 3. 2001-05-24. PMID:11284443. |
since this phenomenon is long-lasting, it was of interest to study which persistent alterations in the activity of dopaminergic neurones or of endogenous opioid systems downstream of dopaminergic synapses in the basal ganglia are involved in the sensitization. |
2001-05-24 |
2023-08-12 |
rat |
| S Patel, C J Hillar. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. The Journal of pharmacology and experimental therapeutics. vol 297. issue 2. 2001-05-21. PMID:11303052. |
these data indicate that the assays used in this study are specific for cerebellar-mediated behavioral deficits, and that these deficits are not mediated by the basal ganglia or cannabinoid-induced alterations in nigrostriatal dopaminergic transmission. |
2001-05-21 |
2023-08-12 |
mouse |
| G Kemoun, L Defebvr. [Gait disorders in Parkinson disease. Clinical description, analysis of posture, initiation of stabilized gait]. Presse medicale (Paris, France : 1983). vol 30. issue 9. 2001-04-19. PMID:11285785. |
from a pathophysiological point of view, gait disorders could result from defective central integration of proprioceptive information during movement within the basal ganglia, associated with a visual perceptive deficit linked with a retinal dopaminergic cells dysfunction and finally from an impairment of the proprioceptive feedback of the load receptors in the leg extensor muscles. |
2001-04-19 |
2023-08-12 |
Not clear |
| T Boraud, E Bezard, B Bioulac, C E Gros. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain : a journal of neurology. vol 124. issue Pt 3. 2001-04-05. PMID:11222455. |
in this study, electrophysiological single-unit recordings of the neuronal activity of the globus pallidus internalis (gpi), the main basal ganglia output structure, and the globus pallidus externalis (gpe) were recorded continuously in both normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treated subhuman primates before and after the administration of three dopamine agonists--apomorphine (a dopaminergic mixed agonist), skf-38393 (a d1 partial agonist) and piribedil (a d2/d3 agonist)--at doses known to induce dyskinesias in the parkinsonian monkey. |
2001-04-05 |
2023-08-12 |
monkey |
| J R Berger, G Arend. HIV dementia: the role of the basal ganglia and dopaminergic systems. Journal of psychopharmacology (Oxford, England). vol 14. issue 3. 2001-03-29. PMID:11106299. |
hiv dementia: the role of the basal ganglia and dopaminergic systems. |
2001-03-29 |
2023-08-12 |
human |
| J R Berger, G Arend. HIV dementia: the role of the basal ganglia and dopaminergic systems. Journal of psychopharmacology (Oxford, England). vol 14. issue 3. 2001-03-29. PMID:11106299. |
in this review, we describe the evidence for involvement of basal ganglia and, in particular, the dopaminergic systems, in hiv dementia. |
2001-03-29 |
2023-08-12 |
human |
| A Nath, C Anderson, M Jones, W Maragos, R Booze, C Mactutus, J Bell, K F Hauser, M Mattso. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. Journal of psychopharmacology (Oxford, England). vol 14. issue 3. 2001-03-29. PMID:11106300. |
infection with the human immunodeficiency virus (hiv) selectively targets the basal ganglia resulting in loss of dopaminergic neurons. |
2001-03-29 |
2023-08-12 |
human |
| M Yamaya, M Yanai, T Ohrui, H Arai, H Sasak. Interventions to prevent pneumonia among older adults. Journal of the American Geriatrics Society. vol 49. issue 1. 2001-03-22. PMID:11207848. |
similarly, since the production of substance p is regulated by dopaminergic neurons in the cerebral basal ganglia, treatment with dopamine analogs or potentiating drugs such as amantadine (and, of course, prevention of cerebral vascular disease, which can result in basal ganglia strokes) should affect the incidence of pneumonia. |
2001-03-22 |
2023-08-12 |
Not clear |
| P A Fall, S Ekberg, A K Granérus, G Granéru. ECT in Parkinson's disease-dopamine transporter visualised by [123I]-beta-CIT SPECT. Journal of neural transmission (Vienna, Austria : 1996). vol 107. issue 8-9. 2001-02-15. PMID:11041278. |
parkinson's disease (pd) is characterised by a loss of dopaminergic neurones in the basal ganglia. |
2001-02-15 |
2023-08-12 |
Not clear |
| V T Shuvalo. [Specific and nonspecific cortical-subcortical mechanisms of behavior]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. vol 86. issue 11. 2001-02-15. PMID:11195206. |
the paper presents data on comparative morphological study of afferent connections between the cat, dog, monkey brain basal ganglia with structures of the "motor" and "limbic" systems, neurophysiological data on specifics of involvement of the pre-frontal cortex, amygdala, caudate nucleus and thalamus in the processes of learning, perception and assessment of the stimuli significance, formation of short- and long-term memory's programs, decision making, programming the actions and assessment of the actions being performed, experimental data on the role of glutamatergic, dopaminergic, cholinergic, gaba-ergic systems of the cortex and a number of subcortical structures in the mechanisms of formation and implementation of the food and defence reflexes. |
2001-02-15 |
2023-08-12 |
dog |
| Y Smith, J Z Kieva. Anatomy of the dopamine system in the basal ganglia. Trends in neurosciences. vol 23. issue 10 Suppl. 2001-02-08. PMID:11052217. |
thus, the long-term belief that the effects of dopamine in the basal ganglia were solely mediated through the nigrostriatal system must be changed to take into account extrastriatal dopaminergic projections and intrastriatal dopaminergic neurons. |
2001-02-08 |
2023-08-12 |
Not clear |
| U Castiello, C Bonfiglioli, R F Peppar. Dopaminergic effects on the implicit processing of distractor objects in Parkinson's disease. Experimental brain research. vol 135. issue 2. 2001-02-08. PMID:11131510. |
results are discussed in light of the role played by the striatal and mesocortical dopaminergic systems for response selection in basal ganglia disorders. |
2001-02-08 |
2023-08-12 |
human |
| T M Tzschentk. The medial prefrontal cortex as a part of the brain reward system. Amino acids. vol 19. issue 1. 2001-02-01. PMID:11026491. |
it receives prominent dopaminergic input from the ventral tegmental area (vta) and, via the mediodorsal thalamus, inputs from other subcortical basal ganglia structures. |
2001-02-01 |
2023-08-12 |
rat |
| A L Benabid, P P Krack, A Benazzouz, P Limousin, A Koudsie, P Polla. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology. vol 55. issue 12 Suppl 6. 2001-02-01. PMID:11188974. |
dyskinesias become drastically attenuated, possibly as a consequence of reduced dopaminergic medication but also because stn dbs may stabilize basal ganglia output activity, thus avoiding the problems associated with standard levodopa replacement therapy. |
2001-02-01 |
2023-08-12 |
Not clear |
| C J Earley, R P Allen, J L Beard, J R Conno. Insight into the pathophysiology of restless legs syndrome. Journal of neuroscience research. vol 62. issue 5. 2000-12-22. PMID:11104500. |
studies looking at basal ganglia dopaminergic function using pet and spect techniques have shown a decrease in binding potential for the dopamine receptor and transporter. |
2000-12-22 |
2023-08-12 |
Not clear |
| J Sevcík, K Mase. Potential role of cannabinoids in Parkinson's disease. Drugs & aging. vol 16. issue 6. 2000-11-30. PMID:10939305. |
the lack of dopaminergic neurons is reflected by a disturbed balance of the neural circuitry in the basal ganglia. |
2000-11-30 |
2023-08-12 |
Not clear |
| C Deransart, V Riban, B Lê, C Marescaux, A Depauli. Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience. vol 100. issue 2. 2000-11-28. PMID:11008171. |
the modulatory and additive effects on absence seizures of dopaminergic neurotransmission through both the d1 and d2 receptors in the core of the nucleus accumbens further suggest that ventral pathways of the basal ganglia system are involved in the modulation of absence seizures. |
2000-11-28 |
2023-08-12 |
rat |